Walmart Inc. said on Monday, Oct. 17, that it would start selling hearing aids over the counter. The retail company revealed that customers could buy the device even without a prescription and a medical exam by a doctor.
Walmart’s announcement comes shortly after the US Food and Drug Administration (USFDA) confirmed that a rule related to hearing aids had been officially changed. Companies have already been waiting for a long-time for this modification, and finally, it was approved.
As per CNN Business, with the new rule, rather than going to a hearing health doctor to get a prescription or have a custom fitting, individuals with mild to moderate hearing impairment can now simply go to stores like Walmart to buy hearing aids.
Shoppers can get over-the-counter hearing aids easily at select Walmart locations across the United States. Then again, it should be noted that the store will only sell to buyers who are 18 years old and above. Their case of hearing loss should also be just mild-to-moderate.
The confirmed Walmart locations where people can avail of the OTC hearing devices include the store’s Vision Centers in Ohio, Michigan, Colorado, Missouri, Tennessee, Texas, and Pennsylvania. The FDA said its rule change would make hearing aids much more widely available and much cheaper across the country.
The new rule that was approved by the feds will allow people to save as much as $2,800 for a pair of hearing aids. These devices are not cheap, so the changed rule was most welcomed by the public and retail outlets.
Walmart will be offering different types of OTC hearing aids, and prices may range from $199 to $999 per pair. Customers can also choose from the hearing aid brands such as Bose’s Lexie and HearX for affordable prices.
“A person’s ‘whole health’ is a combination of many factors, including hearing, that influence physical and mental well-being,” Walmart’s chief medical officer, Dr. John Wigneswaran, said in a press release. “Offering easy access to OTC hearing aids is something that seems quite small and is a solution that can improve our customer’s health outcomes and their ability to live better and healthier.”


U.S. Stocks Slip as Gold Rebounds Ahead of Year-End, Markets Eye 2026 Outlook
Toyota Recalls 162,000 Tundra Vehicles in U.S. Over Multimedia Display Issue
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos
South Korean Won Slides Despite Government Efforts to Stabilize Currency Markets
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns
China Manufacturing PMI Rebounds in December, Offering Boost to Economic Growth Outlook
Embraer Targets Growth as Regional Jet Demand Surges Post-Pandemic
Ryanair Profit Slumps in Q3 After Italy Antitrust Fine Despite Revenue Growth
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
Oil Prices Stabilize at Start of 2026 as OPEC+ Policy and Geopolitical Risks Shape Market Outlook
Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel
Airbus CEO Warns Staff to Prepare for Rising Geopolitical Risks Amid Trade Tensions
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
U.S. Dollar Starts 2026 Weak as Yen, Euro and Sterling Hold Firm Amid Rate Cut Expectations
Shell Plc Downgraded by RBC as Market Headwinds Pressure Valuation
Asia Manufacturing PMI Rebounds as Exports and Tech Demand Drive Growth into 2026 



